DISC MEDICINE ANNOUNCES COMPLETION OF ENROLLMENT OF PHASE 3 APOLLO TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA
DISC MEDICINE INC - APOLLO STUDY RESULTS EXPECTED IN Q4 2026
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.